Table 1 Patient characteristics
From: Poor sleep quality is associated with exercise limitation in precapillary pulmonary hypertension
IPAH | CTEPH | |
|---|---|---|
Number of patients | 52 | 64 |
Age (yrs.) | 58.2 ± 2.0 | 62.7 ± 1.7 |
Females (n/%) | 39/75.0 | 39/60.9 |
BMI (kg/m2) | 26.1 ± 0.9 | 27.4 ± 0.7 |
NYHA FC | 2.6 ± 0.1 | 2.6 ± 0.1 |
BNP (pg/ml) | 171 ± 34 | 120 ± 29 |
6MWT distance (m) | 393 ± 20 | 375 ± 14 |
Mean PAP (mm Hg) | 45.3 ± 1.9 | 42.0 ± 1.5 |
PVR (dyn) | 718 ± 62 | 647 ± 41 |
CI (l/min/m2) | 2.7 ± 0.1 | 2.3 ± 0.1 |
CVP (mm Hg) | 6.2 ± 0.6 | 6.2 ± 0.5 |
PCWP (mm Hg) | 8.5 ± 0.5 | 8.9 ± 0.4 |
FEV1 (% of pred.) | 81.9 ± 3.0 | 79.0 ± 2.3 |
IVC (% of pred.) | 92.5 ± 2.9 | 87.7 ± 1.9 |
FEV1/IVC (% of pred.) | 91.4 ± 1.6 | 92.1 ± 1.6 |
DLCO (% of pred.) | 70.5 ± 2.1 | 74.6 ± 1.9 |
pO2 (mm Hg) | 68.2 ± 1.6 | 65.9 ± 1.1 |
pCO2 (mm Hg) | 34.3 ± 0.8 | 35.7 ± 0.8 |
LTOT (n / %) | 20/38.5 | 26/40.6 |
Oral anticoagulation (n/%) | 37/71.2 | 63/98.4 |
Diuretics (n/%) | 43/82.7 | 47/73.4 |
No vasodilator therapy (n/%) | 11/21.2 | 16/25.0 |
Vasodilator monotherapy (n/%) | 24/46.2 | 33/51.6 |
Vasodilator combination therapy (n/%) | 17/32.7 | 15/23.4 |